UEEC (United Health Products) YoY EPS Growth: 8.33% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is United Health Products YoY EPS Growth?

United Health Products UEEC -1.86% YoY EPS Growth is 8.33% as of Jun. 2026. The stock has 2 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. United Health Products's YoY EPS Growth for the quarter that ended in Jun. 2026 was 8.33%.

United Health Products's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was $-0.00.

United Health Products YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for United Health Products's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

United Health Products YoY EPS Growth Chart

United Health Products Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -58.25 94.53 -48.65 26.36 -28.40

United Health Products Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.41 8.33 34.38 80.00 8.33

United Health Products YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

United Health Products's YoY EPS Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EPS Growth (A: Dec. 2025 )
=(Earnings per Share (Diluted) (A: Dec. 2025 )-Earnings per Share (Diluted) (A: Dec. 2024 ))/ | Earnings per Share (Diluted) (A: Dec. 2024 ) |
=(-0.0104--0.0081)/ | -0.0081 |
=-28.40 %

United Health Products's YoY EPS Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EPS Growth (Q: Jun. 2026 )
=(Earnings per Share (Diluted) (Q: Jun. 2026 )-Earnings per Share (Diluted) (Q: Jun. 2025 )) / | Earnings per Share (Diluted) (Q: Jun. 2025 )) |
=(-0.0011--0.0012)/ | -0.0012 |
=8.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 8.33% mean?
United Health Products (UEEC) has a YoY EPS Growth of 8.33% as of Jun. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for United Health Products and its competitors.
Is United Health Products' YoY EPS Growth too high?
United Health Products' current YoY EPS Growth is 8.33%.
How does United Health Products' YoY EPS Growth compare to CUPR and LUCY?
United Health Products' YoY EPS Growth of 8.33% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Medical Devices & Instruments company?
A good YoY EPS Growth depends on the Medical Devices & Instruments industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for United Health Products and its competitors. United Health Products's current YoY EPS Growth is 8.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Health Products stock overvalued right now?
United Health Products (UEEC) has a current YoY EPS Growth of 8.33%. The current YoY EPS Growth is 8.33%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For United Health Products (UEEC), the current YoY EPS Growth is 8.33% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

United Health Products Business Description

Address 520 Fellowship Road, Suite No D-406, Mt. Laurel, NJ, USA, 08054
United Health Products Inc. is a medical device company focused on developing, manufacturing, and commercializing hemostatic gauze products for the healthcare and wound care markets. Its principal product, HemoStyp, is a patented hemostatic gauze made from regenerated oxidized cellulose that is designed to control bleeding and absorb exudate from wounds. The company is pursuing regulatory clearances to sell its products in the United States Class III human surgical market and in international markets requiring CE Mark certification. It operates as a single business segment centered on the development and commercialization of its hemostatic gauze technology. Target customers include hospitals, surgical centers, and wound care providers, though commercialization to date has been limited and much of its revenue has come from early-stage product sales and distribution arrangements while it seeks broader regulatory approvals.